Amgen will acquire Horizon Therapeutics, which focuses on treatments for rare, autoimmune diseases, in a deal valued at approximately $26.4 billion.
Was this article helpful?
YesNo
Accountability Lab Community of Practice
Accountability Lab Community of Practice
Amgen will acquire Horizon Therapeutics, which focuses on treatments for rare, autoimmune diseases, in a deal valued at approximately $26.4 billion.